Navigation Links
Demi Lovato Joins National Bullying Prevention Movement
Date:8/4/2009

MINNEAPOLIS, Aug. 4 /PRNewswire/ -- Hollywood Records pop music sensation and Disney Channel star, Demi Lovato, today announced a partnership with PACER Center's National Center for Bullying Prevention to help champion their anti-bullying movement. With this announcement, Lovato, whose new album "Here We Go Again," skyrocketed to the #1 position on the Billboard album charts one week ago, now has a platform for a cause she cares about deeply.

It might be hard to imagine that Demi Lovato was the target of bullying when she was younger, but she was and she now has joined forces with the Minneapolis-based PACER Center. Lovato will support the non-profit national center by appearing on PACER's soon-to-be-launched (August 8th) TeensAgainstBullying.org Web site. TeensAgainstBullying.org is an innovative bullying prevention educational resource where teens themselves participate in the creative process of developing concepts, content, artwork and the voice for the site.

"We are so fortunate to have Demi join our Teens Against Bullying movement," said Paula F. Goldberg, executive director and co-founder of PACER. "Our mission is to engage, educate and empower teens to care about the issue and Demi will certainly raise the level of awareness of the importance of bullying prevention. Her personal experiences with bullying have made her passionate about educating others about this cause."

PACER will also promote its relationship with Lovato through its Web site and a social networking campaign that looks to create more awareness for the cause during the 4th Annual National Bullying Prevention Awareness Week (October 4 to 10). During that week, PACER encourages schools and communities nationwide to work together to increase awareness of the prevalence and impact of bullying on all children. Families, students, schools, organizations and other groups can partner with PACER (at PAC
'/>"/>

SOURCE PACER Center
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related medicine news :

1. The American Partnership for Eosinophilic Disorders (APFED) Honors Disney Star Demi Lovato and the Jonas Groups Ned Specktor, as 2009-2010 Honorary Ambassadors of Education
2. The Walt Disney Company Is Presenting Miley Cyrus, Jonas Brothers and Demi Lovato in a Special Concert to Benefit City of Hope on September 14
3. Omaha School of Massage Therapy Adds Healthcare Programs, Joins Herzing University, and Changes Name
4. Professor Bruce Beutler Joins aTyr Pharmas Scientific Advisory Board
5. F. Duwaine Townsen Joins SpectraScience Board of Directors
6. Mayor Menino Joins The Salvation Army to Celebrate the Groundbreaking of the Kroc Community Center
7. Tampa-Saint Petersburg Area Spinal Surgeon Joins Political Leaders in Washington, DC to Discuss America's Healhcare
8. Terrisca Des Jardins, MHSA, joins my1HIE as Director of Strategic Partnerships
9. Ned Russell Joins Saatchi & Saatchi Wellness
10. Fran Lunger Joins Linden as Operating Partner
11. JACQUES Initiative Joins Maryland AIDS Administration to Extend HIV Testing to the Faith-Based Community
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine News(10 mins):Health News:REES Announces New Baltimore Office 2Health News:White Pine Systems and Pediatric Web Announce Partnership to Deliver Interoperable and Brandable PHR Solution for Pediatric and Family Practices 2Health News:White Pine Systems and Pediatric Web Announce Partnership to Deliver Interoperable and Brandable PHR Solution for Pediatric and Family Practices 3Health News:White Pine Systems and Pediatric Web Announce Partnership to Deliver Interoperable and Brandable PHR Solution for Pediatric and Family Practices 4Health News:NVHR Offers Congressman Hank Johnson Support & Encouragement as He Battles Chronic Hepatitis C Virus 2Health News:Pharmacyclics, Inc. Announces Presentation of Interim Results From Phase I Trial of Its First-In-Human Btk Inhibitor PCI-32765 2Health News:Pharmacyclics, Inc. Announces Presentation of Interim Results From Phase I Trial of Its First-In-Human Btk Inhibitor PCI-32765 3Health News:Pharmacyclics, Inc. Announces Presentation of Interim Results From Phase I Trial of Its First-In-Human Btk Inhibitor PCI-32765 4Health News:Pharmacyclics, Inc. Announces Presentation of Interim Results From Phase I Trial of Its First-In-Human Btk Inhibitor PCI-32765 5Health News:Washington Regional Partners with U.S. Preventive Medicine to Bring a New Level of Preventive Health Care Services to Northwest Arkansas 2Health News:Washington Regional Partners with U.S. Preventive Medicine to Bring a New Level of Preventive Health Care Services to Northwest Arkansas 3
Other Medicine News:Health News:Avocados may help prevent oral cancer, OSU study shows 2Health News:Ovation further advances development pipeline with new phase III epilepsy study 2Health News:Research Links TV/Video Game Playing With Child Obesity; Health Experts Back a New Approach 2Health News:Amid Improving Life Expectancy Rates, Risk of Premature Death is Still Significant for Americans, New Study Shows 2Health News:Amid Improving Life Expectancy Rates, Risk of Premature Death is Still Significant for Americans, New Study Shows 3Health News:Amid Improving Life Expectancy Rates, Risk of Premature Death is Still Significant for Americans, New Study Shows 4Health News:Biotech Finishes on a High in August, Burrill Report Says 2Health News:Biotech Finishes on a High in August, Burrill Report Says 3Health News:Biotech Finishes on a High in August, Burrill Report Says 4Health News:Biotech Finishes on a High in August, Burrill Report Says 5Health News:UPMC Health Plan Launches New Personal Health Record 2Health News:UPMC Health Plan Launches New Personal Health Record 3
Breaking Medicine Technology:For Treatment of Metastatic Colorectal Cancer, Avastin Will Face Increasing Competition From Erbitux in Europe, Most Notably in Spain 2For Treatment of Metastatic Colorectal Cancer, Avastin Will Face Increasing Competition From Erbitux in Europe, Most Notably in Spain 3Genoptix Announces Participation at Deutsche Bank 2009 MedTools Investor Conference 2Merieux Alliance Becomes Institut Merieux 2Merieux Alliance Becomes Institut Merieux 3Merieux Alliance Becomes Institut Merieux 4Prize4Life and the Alzheimer Research Forum Announce Launch of New Web Portal for ALS Research 47980 1Prize4Life and the Alzheimer Research Forum Announce Launch of New Web Portal for ALS Research 47980 2Prize4Life and the Alzheimer Research Forum Announce Launch of New Web Portal for ALS Research 47980 3MassMutual Survey 3A Female Cancer Survivors Better Prepared Financially Than Other Women For Lifes Unexpected Events 47976 1MassMutual Survey 3A Female Cancer Survivors Better Prepared Financially Than Other Women For Lifes Unexpected Events 47976 2MassMutual Survey 3A Female Cancer Survivors Better Prepared Financially Than Other Women For Lifes Unexpected Events 47976 3MassMutual Survey 3A Female Cancer Survivors Better Prepared Financially Than Other Women For Lifes Unexpected Events 47976 4MassMutual Survey 3A Female Cancer Survivors Better Prepared Financially Than Other Women For Lifes Unexpected Events 47976 5Association found between Parkinsons disease and pesticide exposure in French farm workers 47972 1Association found between Parkinsons disease and pesticide exposure in French farm workers 47972 2
Other Medicine Technology:New Keppra XR(TM) Data Highlight Its Role for Patients with Partial-Onset Seizures 2New Keppra XR(TM) Data Highlight Its Role for Patients with Partial-Onset Seizures 3New Keppra XR(TM) Data Highlight Its Role for Patients with Partial-Onset Seizures 4New Keppra XR(TM) Data Highlight Its Role for Patients with Partial-Onset Seizures 5New Keppra XR(TM) Data Highlight Its Role for Patients with Partial-Onset Seizures 6Video: Tasigna(R) Demonstrates Rapid Response as Initial Therapy in Life-Threatening Form of Leukemia 2Video: Tasigna(R) Demonstrates Rapid Response as Initial Therapy in Life-Threatening Form of Leukemia 3Video: Tasigna(R) Demonstrates Rapid Response as Initial Therapy in Life-Threatening Form of Leukemia 4Video: Tasigna(R) Demonstrates Rapid Response as Initial Therapy in Life-Threatening Form of Leukemia 5Video: Tasigna(R) Demonstrates Rapid Response as Initial Therapy in Life-Threatening Form of Leukemia 6Video: Tasigna(R) Demonstrates Rapid Response as Initial Therapy in Life-Threatening Form of Leukemia 7Video: Tasigna(R) Demonstrates Rapid Response as Initial Therapy in Life-Threatening Form of Leukemia 8Video: Tasigna(R) Demonstrates Rapid Response as Initial Therapy in Life-Threatening Form of Leukemia 9Video: Tasigna(R) Demonstrates Rapid Response as Initial Therapy in Life-Threatening Form of Leukemia 10Video: Tasigna(R) Demonstrates Rapid Response as Initial Therapy in Life-Threatening Form of Leukemia 11Video: Tasigna(R) Demonstrates Rapid Response as Initial Therapy in Life-Threatening Form of Leukemia 12Video: Tasigna(R) Demonstrates Rapid Response as Initial Therapy in Life-Threatening Form of Leukemia 13